3-methylcrotonyl CoA carboxylase (3-MCC) deficiency is an inborn error of leucine amino acid metabolism. An isolated enzyme deficiency should be differentiated from biotin metabolism disorder which has all of the four carboxylase deficiencies. With the advent of tandem mass spectrometry (TMS), high number of infants have been diagnosed with 3-MCC deficiency. Most neonates having 3-MCC deficiency appear normal, studies have shown an increased risk of developmental and metabolic abnormalities. Universal newborn screening is not routinely done in India. Many infants with 3-MCC deficiency may be missed at birth and may present with symptoms later in life. We reported a case of four and a half month old male infant with seizures due to 3-MCC deficiency. Very few data on 3-MCC deficiency is available in India and hence this case report.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.